← Evidence map

ArticleNutrients2026

Advances in Nutrition for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Management: Current Perspectives from the Bench to the Bedside.

Ildefonso Rodriguez-RamiroPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Advances in Nutrition for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Management: Current Perspectives from the Bench to the Bedside. | Socratic